Innovative Medtech Profitability Analysis

IMTH -  USA Stock  

USD 0.58  0.07  10.77%

For Innovative Medtech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Innovative Medtech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Innovative Medtech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Innovative Medtech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Innovative Medtech over time as well as its relative position and ranking within its peers. Please see Risk vs Return Analysis.

Innovative Current Profitability Trends 

 
Refresh
The market value of Innovative Medtech is measured differently than its book value, which is the value of Innovative that is recorded on the company's balance sheet. Investors also form their own opinion of Innovative Medtech's value that differs from its market value or its book value, called intrinsic value, which is Innovative Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovative Medtech's market value can be influenced by many factors that don't directly affect Innovative Medtech underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovative Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine Innovative Medtech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovative Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Innovative Medtech Number of Employees vs. Beta Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Innovative Medtech's current stock value. Our valuation model uses many indicators to compare Innovative Medtech value to that of its competitors to determine the firm's financial worth.
Innovative Medtech is rated fourth overall in beta category among related companies. It is rated below average in number of employees category among related companies creating about  2.13  of Number of Employees per Beta.

Innovative Number of Employees vs. Beta

Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it will be expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Innovative Medtech 
Beta 
 = 
Covariance 
Variance 
0.47
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Innovative Medtech 
Number of Employees 
 = 
Full Time 
+  
Part Time 
1
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.

Innovative Number of Employees vs Competition

Innovative Medtech is rated below average in number of employees category among related companies. The total workforce of Medical Instruments & Supplies industry is currently estimated at about 154,044. Innovative Medtech adds roughly 1.0 in number of employees claiming only tiny portion of all equities under Medical Instruments & Supplies industry.

Innovative Medtech Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Innovative Medtech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Innovative Medtech will eventually generate negative long term returns. The profitability progress is the general direction of Innovative Medtech's change in net profit over the period of time. It can combine multiple indicators of Innovative Medtech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Innovative MedTech Inc. provides natural and organic food products. Innovative MedTech Inc. is headquartered in New York, New York. Innovative Medtech operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 1 people.

Innovative Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Innovative Medtech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Innovative Medtech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Innovative Medtech's important profitability drivers and their relationship over time.

Use Innovative Medtech in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Innovative Medtech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medtech will appreciate offsetting losses from the drop in the long position's value.

Innovative Medtech Pair Trading

Innovative Medtech Pair Trading Analysis

Correlation analysis and pair trading evaluation for Innovative Medtech and Becton Dickinson And. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your Innovative Medtech position

In addition to having Innovative Medtech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cars Thematic Idea Now

Cars
Cars Theme
Domestic and international companies involved in manufacturing and serving automobiles and trucks. Cars theme has 30 constituents.
View All  Next Launch Cars
Please see Risk vs Return Analysis. Note that the Innovative Medtech information on this page should be used as a complementary analysis to other Innovative Medtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Innovative OTC Stock analysis

When running Innovative Medtech price analysis, check to measure Innovative Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Medtech is operating at the current time. Most of Innovative Medtech's value examination focuses on studying past and present price action to predict the probability of Innovative Medtech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Innovative Medtech's price. Additionally, you may evaluate how the addition of Innovative Medtech to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
To fully project Innovative Medtech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Innovative Medtech at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Innovative Medtech's income statement, its balance sheet, and the statement of cash flows.
Potential Innovative Medtech investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Innovative Medtech investors may work on each financial statement separately, they are all related. The changes in Innovative Medtech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Innovative Medtech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.